Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NeuroPace, Inc. (NPCE)
USD16.25
+0.41 (+2.59%)
US NASDAQ Healthcare Medical - Devices
Address
455 North Bernardo Avenue 94043
Mountain View, CA, US
Mountain View, CA, US
CEO
Joel D. Becker
Website
neuropace.com
IPO
2021-04-22
CIK 1528287 ISIN US6412881053
Description
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD16.25
+0.41 (+2.59%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
185.4K
Beta
1.88
Float Shares
22.94M
Free Float %
67.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.83% | -12.22% | +10.80% | +8.97% | +17.04% | +2.33% | +18.18% | +270.89% | -21.47% | -36.70% | -36.70% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
16.25
Low
19.00
+16.9%
Consensus
20.50
+26.2%
Median
20.50
+26.2%
High
22.00
+35.4%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 5 |
18.80
+15.7%
|
| All Time | 11 |
15.59
-4.1%
|
Quality scores
Altman Z-Score
-2.79
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+25.1% ★ Q1'26: -2.0% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+29.0% ★ Q1'26: +4.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-26.2% Q1'26: -26.7% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-16.3% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-56.7%
-
Share dilution Medical - Devices: 0.0%+12.4% Q1'26: +7.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-4.92× Q1'26: -3.16× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 5 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
45.18M
est: 44.92M (+0.6%)
|
45.52M
est: 45.21M (+0.7%)
|
65.42M
est: 71.82M (-8.9%)
|
79.91M
est: 79.58M (+0.4%)
|
99.99M
est: 95.09M (+5.1%)
|
98.91M
98.48M – 99.14M
+4.0% YoY
|
123.10M
122.27M – 123.94M
+24.5% YoY
|
153.59M
153.59M – 153.59M
+24.8% YoY
|
184.83M
180.86M – 187.56M
+20.3% YoY
|
213.41M
208.83M – 216.57M
+15.5% YoY
|
| EBITDA |
-28.37M
est: -20.58M (-37.9%)
|
-36.57M
est: -20.72M (-76.5%)
|
-22.83M
est: -30.62M (+25.4%)
|
-16.57M
est: -33.93M (+51.2%)
|
-14.39M
est: -40.54M (+64.5%)
|
-42.17M
-42.27M – -41.98M
-4.0% YoY
|
-52.48M
-52.84M – -52.13M
-24.5% YoY
|
-65.48M
-65.48M – -65.48M
-24.8% YoY
|
-78.80M
-79.96M – -77.11M
-20.3% YoY
|
-90.98M
-92.33M – -89.03M
-15.5% YoY
|
| EBIT |
-28.67M
est: -21.72M (-32.0%)
|
-39.55M
est: -21.86M (-80.9%)
|
-24.44M
est: -32.61M (+25.0%)
|
-18.34M
est: -36.13M (+49.2%)
|
-16.34M
est: -43.17M (+62.2%)
|
-44.90M
-45.01M – -44.71M
-4.0% YoY
|
-55.89M
-56.27M – -55.51M
-24.5% YoY
|
-69.73M
-69.73M – -69.73M
-24.8% YoY
|
-83.91M
-85.15M – -82.11M
-20.3% YoY
|
-96.89M
-98.32M – -94.81M
-15.5% YoY
|
| Net Income |
-36.08M
est: -54.79M (+34.1%)
|
-47.08M
est: -57.27M (+17.8%)
|
-32.96M
est: -35.43M (+7.0%)
|
-27.14M
est: -32.14M (+15.5%)
|
-21.47M
est: -25.04M (+14.3%)
|
-21.45M
-28.34M – -14.96M
+14.3% YoY
|
-11.93M
-13.77M – -7.51M
+44.4% YoY
|
-2.52M
-24.27M – 9.63M
+78.9% YoY
|
12.76M
12.41M – 13.01M
+605.9% YoY
|
11.78M
11.45M – 12.01M
-7.7% YoY
|
| SGA |
38.96M
est: 37.82M (+3.0%)
|
51.34M
est: 38.06M (+34.9%)
|
54.52M
est: 60.26M (-9.5%)
|
57.10M
est: 66.77M (-14.5%)
|
65.67M
est: 79.78M (-17.7%)
|
82.98M
82.62M – 83.17M
+4.0% YoY
|
103.28M
102.58M – 103.98M
+24.5% YoY
|
128.86M
128.86M – 128.86M
+24.8% YoY
|
155.07M
151.74M – 157.36M
+20.3% YoY
|
179.05M
175.21M – 181.70M
+15.5% YoY
|
| EPS |
-2.17
est: -1.88 (-15.4%)
|
-1.91
est: -1.97 (+2.9%)
|
-1.27
est: -1.09 (-16.8%)
|
-0.93
est: -0.98 (+5.3%)
|
-0.66
est: -0.77 (+13.7%)
|
-0.61
-0.87 – -0.46
+19.8% YoY
|
-0.34
-0.42 – -0.23
+43.9% YoY
|
-0.09
-0.74 – 0.29
+73.1% YoY
|
0.39
0.38 – 0.40
+521.7% YoY
|
0.36
0.35 – 0.37
-7.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-8.60M
OE per share TTM
-0.27
Owner's Yield
-1.68%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
13.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
18
Total invested
16.08M
Insider transactions (90d)
0
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KCK Ltd. | 5.62M | 4.00% | 5.62M | — | 5.62M | — | OO | British Virgin Islands | 2022-10-07 | ↗ |
| 2 | Accelmed Partners II GP, L.P. | 4.04M | 16.20% | 4.04M | — | 4.04M | — | PN | — | 2022-11-21 | ↗ |
| 3 | Accelmed Partners II LP | 4.04M | 16.20% | 4.04M | — | 4.04M | — | PN | — | 2022-11-21 | ↗ |
| 4 | Accelmed Partners II, LLC | 4.04M | 16.20% | 4.04M | — | 4.04M | — | OO | — | 2022-11-21 | ↗ |
| 5 | Uri Geiger | 4.04M | 16.20% | 4.04M | — | 4.04M | — | IN | — | 2022-11-21 | ↗ |
| 6 | OrbiMed Advisors LLC | 4.01M | 16.80% | — | 4.01M | — | — | IA | Delaware | 2021-04-29 | ↗ |
| 7 | OrbiMed Capital GP VI LLC | 4.01M | 16.80% | — | 4.01M | — | — | OO | Delaware | 2021-04-29 | ↗ |
| 8 | Morgan Stanley | 2.19M | 8.80% | 13.00 | — | — | 13.00 | HC, CO | — | 2023-02-10 | ↗ |
| 9 | Morgan Stanley Capital Services LLC | 2.19M | 8.80% | 13.00 | — | — | 13.00 | BD, CO | — | 2023-02-10 | ↗ |
| 10 | Levy | 1.84M | 7.60% | — | 1.84M | — | 1.84M | IN | Delaware | 2021-11-01 | ↗ |
| 11 | Abigail P. Johnson | 1.45M | 5.82% | — | — | 1.45M | — | IN | United States of America | 2023-02-09 | ↗ |
| 12 | FMR LLC | 1.45M | 5.82% | 1.45M | — | 1.45M | — | HC | Delaware | 2023-02-09 | ↗ |
| 13 | Group, LLC | 1.24M | 5.10% | — | 1.24M | — | 1.24M | OO | Delaware | 2021-11-01 | ↗ |
| 14 | LLC | 1.24M | 5.10% | — | 1.24M | — | 1.24M | OO | Delaware | 2021-11-01 | ↗ |
| 15 | Master Fund, L.P. | 1.24M | 5.10% | — | 1.24M | — | 1.24M | FI | Delaware | 2021-11-01 | ↗ |
| 16 | Covidien Group S.a.r.l. | 965.9K | 3.97% | — | 965.9K | — | — | OO | Ireland | 2022-01-13 | ↗ |
| 17 | Medtronic plc | 965.9K | 3.97% | — | 965.9K | — | — | OO | Ireland | 2022-01-13 | ↗ |
| 18 | Equity Fund I, L.P. | 592.2K | 2.40% | — | 592.2K | — | 592.2K | PN | Delaware | 2021-11-01 | ↗ |
| 19 | Equity GP I, LLC | 592.2K | 2.40% | — | 592.2K | — | 592.2K | OO | Delaware | 2021-11-01 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
18
-82 vs prev Q
New positions
4
Closed positions
86
Increased
8
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | POLAR CAPITAL HOLDINGS PLC | 2.88M -219.3K (-7.1%) | 44.44M +12.5M (+39.2%) | 8.69% -0.739 pp | 0.17% +0.018 pp | USD10.31 +49.8% | 4 qtrs — |
| 2 | SOLEUS CAPITAL MANAGEMENT, L.P. | 2.70M -254.7K (-8.6%) | 41.74M +11.2M (+36.9%) | 8.16% -0.843 pp | 1.54% +0.004 pp | USD16.08 -4.0% | 19 qtrs — |
| 3 | MORGAN STANLEY | 2.55M +1.6K (+0.1%) | 39.34M +13.1M (+49.9%) | 7.69% -0.059 pp | 0.00% +0.001 pp | USD6.85 +125.4% | 19 qtrs — |
| 4 | ORBIMED ADVISORS LLC | 2.41M -207.8K (-8.0%) | 37.15M +10.2M (+37.9%) | 7.26% -0.693 pp | 0.76% +0.126 pp | USD23.79 -35.1% | 19 qtrs — |
| 5 | BLACKROCK, INC. | 2.38M -32.7K (-1.4%) | 36.81M +11.9M (+47.7%) | 7.19% -0.159 pp | 0.00% +0.000 pp | USD9.94 +55.3% | 6 qtrs — |
| 6 | DRIEHAUS CAPITAL MANAGEMENT LLC | 1.51M +571.8K (+60.9%) | 23.33M +13.6M (+140.9%) | 4.56% +1.702 pp | 0.16% +0.089 pp | USD13.34 +15.7% | 4 qtrs — |
| 7 | VANGUARD GROUP INC | 1.48M +46.4K (+3.2%) | 22.89M +8.1M (+54.6%) | 4.47% +0.104 pp | 0.00% +0.000 pp | USD11.87 +30.1% | 19 qtrs — |
| 8 | FIRST LIGHT ASSET MANAGEMENT, LLC | 1.35M -10.6K (-0.8%) | 20.84M +6.8M (+48.6%) | 4.07% -0.066 pp | 1.59% +0.271 pp | USD12.29 +25.6% | 4 qtrs — |
| 9 | DEUTSCHE BANK AG\ | 929.5K +756.0 (+0.1%) | 14.35M +4.8M (+49.9%) | 2.81% -0.021 pp | 0.00% +0.002 pp | USD10.08 +53.2% | 7 qtrs — |
| 10 | ARMISTICE CAPITAL, LLC | 792.0K -506.0K (-39.0%) | 12.23M -1.2M (-8.6%) | 2.39% -1.560 pp | 0.15% -0.053 pp | USD10.01 +54.2% | 6 qtrs — |
| 11 | KOTLER KEVIN | 631.5K +631.5K (+100.0%) | 9.75M +9.7M (+100.0%) | 1.91% +1.906 pp | 2.28% +2.281 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 12 | FMR LLC | 624.9K +625.0 (+0.1%) | 9.65M +3.2M (+49.9%) | 1.89% -0.014 pp | 0.00% +0.000 pp | USD14.31 +7.9% | 19 qtrs — |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 596.2K +36.5K (+6.5%) | 9.21M +3.4M (+59.5%) | 1.80% +0.096 pp | 0.00% +0.000 pp | USD11.16 +38.4% | 19 qtrs — |
| 14 | STATE STREET CORP | 447.9K +40.0K (+9.8%) | 6.92M +2.7M (+64.5%) | 1.35% +0.111 pp | 0.00% +0.000 pp | USD11.02 +40.1% | 19 qtrs — |
| 15 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 396.6K +97.2K (+32.5%) | 6.12M +3.0M (+98.4%) | 1.20% +0.286 pp | 0.04% +0.022 pp | USD13.06 +18.2% | 4 qtrs — |
| 16 | NANTAHALA CAPITAL MANAGEMENT, LLC | 295.1K +— (+0.0%) | 4.56M +1.5M (+49.8%) | 0.89% -0.007 pp | 0.15% +0.045 pp | USD11.00 +40.4% | 19 qtrs — |
| 17 | NORTHERN TRUST CORP | 231.8K -4.7K (-2.0%) | 3.58M +1.1M (+46.8%) | 0.70% -0.020 pp | 0.00% +0.000 pp | USD9.19 +68.0% | 19 qtrs — |
| 18 | WALLEYE CAPITAL LLC | 228.8K +177.4K (+344.6%) | 3.53M +3.0M (+565.8%) | 0.69% +0.534 pp | 0.01% +0.009 pp | USD14.53 +6.3% | 5 qtrs — |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 222.3K +93.2K (+72.2%) | 3.43M +2.1M (+157.9%) | 0.67% +0.278 pp | 0.01% +0.004 pp | USD12.72 +21.4% | 15 qtrs — |
| 20 | PALUMBO WEALTH MANAGEMENT LLC | 214.2K +16.7K (+8.5%) | 3.31M +1.3M (+62.4%) | 0.65% +0.046 pp | 0.82% +0.166 pp | USD11.56 +33.6% | 5 qtrs — |
| 21 | ESSEX INVESTMENT MANAGEMENT CO LLC | 213.9K -2.8K (-1.3%) | 3.30M +1.1M (+47.8%) | 0.65% -0.014 pp | 0.50% +0.162 pp | USD10.98 +40.6% | 4 qtrs — |
| 22 | QUBE RESEARCH & TECHNOLOGIES LTD | 199.0K -14.8K (-6.9%) | 3.07M +868.5K (+39.4%) | 0.60% -0.050 pp | 0.00% +0.001 pp | USD11.09 +39.2% | 10 qtrs — |
| 23 | TUDOR INVESTMENT CORP ET AL | 193.3K +39.6K (+25.8%) | 2.99M +1.4M (+88.4%) | 0.58% +0.116 pp | 0.01% +0.003 pp | USD12.16 +27.0% | 4 qtrs — |
| 24 | ALGERT GLOBAL LLC | 172.9K +75.4K (+77.4%) | 2.67M +1.7M (+165.7%) | 0.52% +0.225 pp | 0.04% +0.025 pp | USD12.97 +19.0% | 3 qtrs — |
| 25 | BANK OF AMERICA CORP /DE/ | 170.4K +112.8K (+195.5%) | 2.63M +2.0M (+342.5%) | 0.51% +0.339 pp | 0.00% +0.000 pp | USD14.12 +9.3% | 19 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 164.7K -21.8K (-11.7%) | 2.54M +619.9K (+32.2%) | 0.50% -0.071 pp | 0.00% +0.000 pp | USD10.82 +42.7% | 8 qtrs — |
| 27 | CITADEL ADVISORS LLC | 131.9K +131.9K (+100.0%) | 2.04M +2.0M (+100.0%) | 0.40% +0.398 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 28 | JPMORGAN CHASE & CO | 130.9K +120.7K (+1,175.0%) | 2.02M +1.9M (+1,809.4%) | 0.40% +0.364 pp | 0.00% +0.000 pp | USD15.08 +2.4% | 9 qtrs — |
| 29 | JANE STREET GROUP, LLC | 117.6K +117.6K (+100.0%) | 1.82M +1.8M (+100.0%) | 0.35% +0.355 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 30 | LAZARD ASSET MANAGEMENT LLC | 113.2K +8.1K (+7.7%) | 1.75M +664.8K (+61.4%) | 0.34% +0.022 pp | 0.00% +0.002 pp | USD11.23 +37.5% | 9 qtrs — |
| 31 | MILLENNIUM MANAGEMENT LLC | 93.7K +93.7K (+100.0%) | 1.45M +1.4M (+100.0%) | 0.28% +0.283 pp | 0.00% +0.001 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 32 | NUVEEN, LLC | 92.8K +61.6K (+197.1%) | 1.43M +1.1M (+344.9%) | 0.28% +0.185 pp | 0.00% +0.000 pp | USD14.22 +8.6% | 4 qtrs — |
| 33 | SEI INVESTMENTS CO | 80.2K +80.2K (+100.0%) | 1.24M +1.2M (+100.0%) | 0.24% +0.242 pp | 0.00% +0.001 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 34 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 76.2K +7.3K (+10.6%) | 1.18M +466.0K (+65.6%) | 0.23% +0.020 pp | 0.00% +0.000 pp | USD9.76 +58.2% | 7 qtrs — |
| 35 | EAM INVESTORS, LLC | 75.8K +75.8K (+100.0%) | 1.17M +1.2M (+100.0%) | 0.23% +0.229 pp | 0.13% +0.130 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 36 | RUSSELL INVESTMENTS GROUP, LTD. | 73.7K +6.5K (+9.6%) | 1.14M +444.9K (+64.2%) | 0.22% +0.018 pp | 0.00% +0.001 pp | USD12.18 +26.8% | 4 qtrs — |
| 37 | LEGATO CAPITAL MANAGEMENT LLC | 69.2K +6.1K (+9.7%) | 1.07M +417.9K (+64.3%) | 0.21% +0.017 pp | 0.09% +0.021 pp | USD11.39 +35.6% | 4 qtrs — |
| 38 | BARCLAYS PLC | 68.6K +47.9K (+232.3%) | 1.06M +914.7K (+636.0%) | 0.21% +0.144 pp | 0.00% +0.000 pp | USD13.86 +11.4% | 16 qtrs — |
| 39 | TWO SIGMA INVESTMENTS, LP | 68.1K +48.8K (+252.9%) | 1.05M +852.4K (+428.5%) | 0.21% +0.147 pp | 0.00% +0.001 pp | USD14.25 +8.4% | 7 qtrs — |
| 40 | HIGHMARK WEALTH MANAGEMENT LLC | 63.0K +— (+0.0%) | 972.7K +323.2K (+49.8%) | 0.19% -0.002 pp | 0.40% +0.111 pp | USD10.94 +41.1% | 6 qtrs — |
| 41 | PRINCIPAL FINANCIAL GROUP INC | 58.4K +18.9K (+47.9%) | 902.0K +494.7K (+121.5%) | 0.18% +0.056 pp | 0.00% +0.000 pp | USD12.23 +26.2% | 3 qtrs — |
| 42 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 58.3K +58.3K (+100.0%) | 899.5K +899.5K (+100.0%) | 0.18% +0.176 pp | 0.00% +0.002 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 43 | PANAGORA ASSET MANAGEMENT INC | 58.0K -1.7K (-2.8%) | 895.6K +280.2K (+45.5%) | 0.18% -0.007 pp | 0.00% +0.001 pp | USD11.14 +38.6% | 3 qtrs — |
| 44 | BANK OF NEW YORK MELLON CORP | 53.8K +1.6K (+3.0%) | 831.4K +292.5K (+54.3%) | 0.16% +0.004 pp | 0.00% +0.000 pp | USD9.63 +60.3% | 7 qtrs — |
| 45 | TWO SIGMA ADVISERS, LP | 51.1K +13.0K (+34.1%) | 789.0K +396.2K (+100.9%) | 0.15% +0.038 pp | 0.00% +0.001 pp | USD12.47 +23.8% | 5 qtrs — |
| 46 | BNP PARIBAS ARBITRAGE, SNC | 46.9K +28.2K (+150.1%) | 724.4K +531.0K (+274.6%) | 0.14% +0.085 pp | 0.00% +0.000 pp | USD13.66 +13.0% | 5 qtrs — |
| 47 | UBS GROUP AG | 44.9K -20.3K (-31.1%) | 693.5K +20.9K (+3.1%) | 0.14% -0.063 pp | 0.00% +0.000 pp | USD10.92 +41.4% | 19 qtrs — |
| 48 | TREXQUANT INVESTMENT LP | 39.2K -17.9K (-31.3%) | 604.6K +16.5K (+2.8%) | 0.12% -0.055 pp | 0.01% -0.001 pp | USD11.44 +35.0% | 4 qtrs — |
| 49 | HSBC HOLDINGS PLC | 37.6K -16.9K (-31.0%) | 579.0K +14.4K (+2.5%) | 0.11% -0.052 pp | 0.00% +0.000 pp | USD11.14 +38.6% | 3 qtrs — |
| 50 | XTX TOPCO LTD | 34.0K +23.0K (+209.1%) | 524.6K +411.2K (+362.9%) | 0.10% +0.069 pp | 0.01% +0.008 pp | USD13.78 +12.0% | 2 qtrs — |
| 51 | WELLS FARGO & COMPANY/MN | 33.1K +13.1K (+65.4%) | 510.9K +304.6K (+147.6%) | 0.10% +0.039 pp | 0.00% +0.000 pp | USD13.00 +18.8% | 13 qtrs — |
| 52 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 31.8K +31.8K (+100.0%) | 491.0K +491.0K (+100.0%) | 0.10% +0.096 pp | 0.00% +0.004 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 53 | MARSHALL WACE, LLP | 31.0K +31.0K (+100.0%) | 479.1K +479.1K (+100.0%) | 0.09% +0.094 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 54 | GSA CAPITAL PARTNERS LLP | 29.9K -24.6K (-45.1%) | 462.0K -100.0K (-17.8%) | 0.09% -0.076 pp | 0.04% -0.007 pp | USD11.17 +38.2% | 5 qtrs — |
| 55 | RHUMBLINE ADVISERS | 29.3K -2.7K (-8.5%) | 452.5K +122.2K (+37.0%) | 0.09% -0.009 pp | 0.00% +0.000 pp | USD9.73 +58.7% | 7 qtrs — |
| 56 | NUMERAI GP LLC | 29.3K +29.3K (+100.0%) | 452.0K +452.0K (+100.0%) | 0.09% +0.088 pp | 0.05% +0.055 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 57 | SQUAREPOINT OPS LLC | 28.0K -33.6K (-54.5%) | 432.6K -202.5K (-31.9%) | 0.08% -0.103 pp | 0.00% 0.000 pp | USD10.72 +44.0% | 3 qtrs — |
| 58 | JUMP FINANCIAL, LLC | 25.7K +25.7K (+100.0%) | 396.8K +396.8K (+100.0%) | 0.08% +0.078 pp | 0.00% +0.005 pp | USD15.44 +0.0% | 4 qtrs — |
| 59 | POINT72 ASSET MANAGEMENT, L.P. | 24.6K +24.6K (+100.0%) | 380.5K +380.5K (+100.0%) | 0.07% +0.074 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 60 | WESTERN WEALTH MANAGEMENT, LLC | 23.0K -50.0 (-0.2%) | 354.3K +117.2K (+49.4%) | 0.07% -0.001 pp | 0.02% +0.004 pp | USD10.31 +49.8% | 2 qtrs — |
| 61 | MAN GROUP PLC | 21.6K +1.9K (+9.7%) | 333.9K +130.7K (+64.3%) | 0.07% +0.005 pp | 0.00% +0.000 pp | USD10.77 +43.4% | 2 qtrs — |
| 62 | CANADA PENSION PLAN INVESTMENT BOARD | 20.2K +20.2K (+100.0%) | 311.9K +311.9K (+100.0%) | 0.06% +0.061 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 63 | STATE OF WISCONSIN INVESTMENT BOARD | 17.8K +17.8K (+100.0%) | 275.6K +275.6K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.001 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 64 | LOS ANGELES CAPITAL MANAGEMENT LLC | 26.8K +425.0 (+1.6%) | 264.4K -7.7K (-2.8%) | 0.08% +0.001 pp | 0.00% +0.000 pp | USD10.39 +48.6% | 2 qtrs — |
| 65 | ROYAL BANK OF CANADA | 15.5K -14.3K (-48.1%) | 239.0K -69.0K (-22.4%) | 0.05% -0.044 pp | 0.00% +0.000 pp | USD10.47 +47.5% | 11 qtrs — |
| 66 | METLIFE INVESTMENT MANAGEMENT, LLC | 15.3K +— (+0.0%) | 236.0K +78.4K (+49.8%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD11.17 +38.2% | 5 qtrs — |
| 67 | PRICE T ROWE ASSOCIATES INC /MD/ | 14.8K +2.8K (+23.0%) | 230.0K +105.0K (+84.0%) | 0.04% +0.008 pp | 0.00% +0.000 pp | USD11.95 +29.2% | 3 qtrs — |
| 68 | ENGINEERS GATE MANAGER LP | 12.2K +12.2K (+100.0%) | 187.6K +187.6K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.002 pp | USD15.44 +0.0% | 4 qtrs — |
| 69 | ENTRYPOINT CAPITAL, LLC | 12.0K +12.0K (+100.0%) | 184.6K +184.6K (+100.0%) | 0.04% +0.036 pp | 0.07% +0.072 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 70 | INVESCO LTD. | 11.9K +11.9K (+100.0%) | 184.3K +184.3K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 71 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11.9K +559.0 (+4.9%) | 183.0K +66.6K (+57.2%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD9.12 +69.3% | 6 qtrs — |
| 72 | PHARVISION ADVISERS, LLC | 11.7K -10.8K (-47.9%) | 180.6K -50.9K (-22.0%) | 0.04% -0.033 pp | 0.09% -0.039 pp | USD10.31 +49.8% | 2 qtrs — |
| 73 | PFM HEALTH SCIENCES, LP | 11.3K +11.3K (+100.0%) | 174.9K +174.9K (+100.0%) | 0.03% +0.034 pp | 0.02% +0.017 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 74 | AQUATIC CAPITAL MANAGEMENT LLC | 10.4K -11.8K (-53.2%) | 160.7K -68.4K (-29.9%) | 0.03% -0.036 pp | 0.00% +0.000 pp | USD10.31 +49.8% | 2 qtrs — |
| 75 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 10.2K +10.2K (+100.0%) | 157.3K +157.3K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.002 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 76 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10.1K +10.1K (+100.0%) | 156.3K +156.3K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 5 qtrs — |
| 77 | QUEST PARTNERS LLC | 9.0K -8.1K (-47.6%) | 138.2K -37.9K (-21.5%) | 0.03% -0.025 pp | 0.01% -0.004 pp | USD10.67 +44.7% | 3 qtrs — |
| 78 | NEW YORK STATE COMMON RETIREMENT FUND | 7.7K +6.8K (+755.6%) | 118.9K +109.6K (+1,181.3%) | 0.02% +0.021 pp | 0.00% +0.000 pp | USD14.49 +6.6% | 7 qtrs — |
| 79 | SG AMERICAS SECURITIES, LLC | 7.6K +7.6K (+100.0%) | 118.0K +118.0K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 80 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 7.7K -7.2K (-48.5%) | 116.2K -37.1K (-24.2%) | 0.02% -0.022 pp | 0.00% +0.000 pp | USD11.14 +38.6% | 3 qtrs — |
| 81 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 6.4K +— (+0.0%) | 98.4K +32.7K (+49.8%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD11.17 +38.2% | 5 qtrs — |
| 82 | ACADIAN ASSET MANAGEMENT LLC | 3.2K +3.2K (+100.0%) | 49.0K +49.0K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 83 | LEGAL & GENERAL GROUP PLC | 2.6K -77.0 (-2.9%) | 40.2K +12.6K (+45.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD9.09 +69.9% | 7 qtrs — |
| 84 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.5K +578.0 (+29.8%) | 38.8K +18.9K (+94.5%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD12.43 +24.2% | 19 qtrs — |
| 85 | AMERITAS INVESTMENT PARTNERS, INC. | 2.5K +— (+0.0%) | 37.9K +12.6K (+49.8%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD9.06 +70.4% | 7 qtrs — |
| 86 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1.6K +67.0 (+4.5%) | 24.2K +8.7K (+56.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.91 +73.3% | 7 qtrs — |
| 87 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1.2K -50.0 (-4.0%) | 18.5K +5.6K (+43.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD12.21 +26.5% | 4 qtrs — |
| 88 | QUARRY LP | 790.00 -3.1K (-79.5%) | 12.2K -27.4K (-69.2%) | 0.00% -0.009 pp | 0.00% -0.007 pp | USD10.74 +43.8% | 3 qtrs — |
| 89 | AMALGAMATED BANK | 800.00 +328.0 (+69.5%) | 12.0K +7.0K (+140.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD10.65 +45.0% | 7 qtrs — |
| 90 | KEMNAY ADVISORY SERVICES INC. | 653.00 +653.0 (+100.0%) | 10.1K +10.1K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.002 pp | USD15.44 +0.0% | 1 qtrs NEW |
| 91 | CITIGROUP INC | 576.00 -458.0 (-44.3%) | 8.9K -1.8K (-16.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD8.82 +75.1% | 10 qtrs — |
| 92 | OPTIVER HOLDING B.V. | 270.00 -162.0 (-37.5%) | 4.2K -285.0 (-6.4%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD10.31 +49.8% | 2 qtrs — |
| 93 | STERLING CAPITAL MANAGEMENT LLC | 156.00 +98.0 (+169.0%) | 2.4K +1.8K (+302.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD13.46 +14.7% | 6 qtrs — |
| 94 | CWM, LLC | 156.00 -72.0 (-31.6%) | 2.0K +— (+0.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD12.72 +21.4% | 8 qtrs — |
| 95 | NISA INVESTMENT ADVISORS, LLC | 53.00 +— (+0.0%) | 818.00 +272.0 (+49.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.17 +89.0% | 6 qtrs — |
| 96 | SOUND INCOME STRATEGIES, LLC | 21.00 +— (+0.0%) | 356.00 +129.0 (+56.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD12.29 +25.6% | 4 qtrs — |
| 97 | SBI SECURITIES CO., LTD. | 20.00 -1.0 (-4.8%) | 309.00 +92.0 (+42.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD11.10 +39.1% | 5 qtrs — |
| 98 | HUGHES FINANCIAL SERVICES, LLC | 14.00 +14.0 (+100.0%) | 216.00 +216.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.43 +0.1% | 1 qtrs NEW |
| 99 | LARSON FINANCIAL GROUP LLC | 11.00 +11.0 (+100.0%) | 170.00 +170.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.36 +0.5% | 4 qtrs — |
| 100 | GAMMA INVESTING LLC | 9.00 +9.0 (+100.0%) | 139.00 +139.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.33 +0.7% | 4 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 46 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Health Care Equipment ETF XHE | 0.43% | 650.1K | 0.35% |
| 2 | iShares Micro-Cap ETF IWC | 0.10% | 1.52M | 0.60% |
| 3 | Xtrackers MSCI World Swap UCITS ETF 1C XMWD.L | 0.09% | 12.74M | 0.45% |
| 4 | Xtrackers - Xtrackers MSCI World Swap UCITS ETF 4C - EUR Hedged XWEH.DE | 0.09% | 12.72M | 0.39% |
| 5 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.04% | 367.0K | 0.20% |
| 6 | iShares Russell 2000 Growth ETF IWO | 0.03% | 4.27M | 0.24% |
| 7 | Xtrackers S&P 500 Swap UCITS ETF 1D XSXD.L | 0.03% | 2.83M | 0.07% |
| 8 | Xtrackers S&P 500 Swap UCITS ETF 5C EUR Hedged XS5E.DE | 0.03% | 2.83M | 0.20% |
| 9 | Xtrackers S&P 500 Swap UCITS ETF XS5G.L | 0.03% | 2.83M | 0.20% |
| 10 | Xtrackers S&P 500 Swap UCITS ETF 1C XSPU.L | 0.03% | 2.83M | 0.15% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.67
Neutral
Ratio by volume
0.38
Bearish
Buys
4
Sells
6
Shares acquired
4.8K
Shares disposed
12.6K
Cash buys
—
Cash sales
—
Net activity
-7,843
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,341 | 13.27 | 17.8K | 47,283 | D | ↗ |
| 2026-03-20 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 865 | 13.00 | 11.2K | 14,754 | D | ↗ |
| 2026-03-20 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,153 | 13.00 | 15.0K | 19,160 | D | ↗ |
| 2026-03-20 | Geiger Uri | Director | A-Award | A | Common Stock | 913 | 13.00 | 11.9K | 14,858 | D | ↗ |
| 2026-03-20 | Fischer Frank M | Director | A-Award | A | Common Stock | 1,826 | 13.00 | 23.7K | 595,177 | D | ↗ |
| 2026-03-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,340 | 13.83 | 18.5K | 48,624 | D | ↗ |
| 2026-03-03 | Becker Joel | Director / Officer | F-InKind | D | Common Stock | 5,023 | 13.83 | 69.5K | 96,937 | D | ↗ |
| 2026-02-27 | Morrell Martha | Officer | F-InKind | D | Common Stock | 358 | 14.58 | 5.2K | 74,964 | D | ↗ |
| 2026-02-27 | Becker Joel | Director / Officer | F-InKind | D | Common Stock | 1,126 | 14.58 | 16.4K | 101,960 | D | ↗ |
| 2026-02-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,412 | 14.34 | 48.9K | 75,322 | D | ↗ |
| 2025-12-19 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 678 | 16.59 | 11.2K | 13,889 | D | ↗ |
| 2025-12-19 | Kumar Rakhi | Director | A-Award | A | Common Stock | 904 | 16.59 | 15.0K | 18,007 | D | ↗ |
| 2025-12-19 | Geiger Uri | Director | A-Award | A | Common Stock | 715 | 16.59 | 11.9K | 13,945 | D | ↗ |
| 2025-12-19 | Fischer Frank M | Director | A-Award | A | Common Stock | 1,431 | 16.59 | 23.7K | 593,351 | D | ↗ |
| 2025-12-15 | Morrell Martha | Officer | S-Sale | D | Common Stock | 25,000 | 15.97 | 399.3K | 49,964 | D | ↗ |
| 2025-12-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,338 | 16.66 | 22.3K | 78,734 | D | ↗ |
| 2025-11-27 | Morrell Martha | Officer | F-InKind | D | Common Stock | 357 | 16.50 | 5.9K | 80,072 | D | ↗ |
| 2025-11-27 | Becker Joel | Director / Officer | F-InKind | D | Common Stock | 1,126 | 16.50 | 18.6K | 103,086 | D | ↗ |
| 2025-11-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,051 | 13.50 | 41.2K | 80,429 | D | ↗ |
| 2025-09-19 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 1,131 | 9.94 | 11.2K | 13,211 | D | ↗ |
| 2025-09-19 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,509 | 9.94 | 15.0K | 17,103 | D | ↗ |
| 2025-09-19 | Geiger Uri | Director | A-Award | A | Common Stock | 1,194 | 9.94 | 11.9K | 13,230 | D | ↗ |
| 2025-09-19 | Fischer Frank M | Director | A-Award | A | Common Stock | 2,389 | 9.94 | 23.7K | 591,920 | D | ↗ |
| 2025-09-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,337 | 9.36 | 12.5K | 83,480 | D | ↗ |
| 2025-08-27 | Morrell Martha | Officer | F-InKind | D | Common Stock | 357 | 8.88 | 3.2K | 84,817 | D | ↗ |
| 2025-08-27 | Becker Joel | Director / Officer | F-InKind | D | Common Stock | 1,126 | 8.88 | 10.0K | 104,212 | D | ↗ |
| 2025-08-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,052 | 8.66 | 26.4K | 85,174 | D | ↗ |
| 2025-06-21 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 1,080 | 10.41 | 11.2K | 12,080 | D | ↗ |
| 2025-06-21 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,440 | 10.41 | 15.0K | 15,594 | D | ↗ |
| 2025-06-21 | Geiger Uri | Director | A-Award | A | Common Stock | 1,140 | 10.41 | 11.9K | 12,036 | D | ↗ |
| 2025-06-21 | Fischer Frank M | Director | A-Award | A | Common Stock | 2,281 | 10.41 | 23.7K | 589,531 | D | ↗ |
| 2025-06-20 | Williams Patrick F. | Officer | A-Award | A | Stock Option (Right to Buy) | 87,950 | 10.41 | 915.6K | 87,950 | D | ↗ |
| 2025-06-06 | Ryan Renee | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-06 | LACOB JOSEPH | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-06 | Kumar Rakhi | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-06 | Huennekens R Scott | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-06 | Geiger Uri | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-06 | Fischer Frank M | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-06 | Andrade Lisa | Director | A-Award | A | Stock Option (right to buy) | 8,745 | 13.15 | 115.0K | 8,745 | D | ↗ |
| 2025-06-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,338 | 13.54 | 18.1K | 85,943 | D | ↗ |
| 2025-06-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,337 | 13.54 | 18.1K | 131,613 | D | ↗ |
| 2025-05-27 | Morrell Martha | Officer | F-InKind | D | Common Stock | 357 | 12.66 | 4.5K | 87,281 | D | ↗ |
| 2025-05-27 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 357 | 12.66 | 4.5K | 132,950 | D | ↗ |
| 2025-05-27 | Becker Joel | Director / Officer | F-InKind | D | Common Stock | 1,126 | 12.66 | 14.3K | 105,338 | D | ↗ |
| 2025-05-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,051 | 17.99 | 54.9K | 87,638 | D | ↗ |
| 2025-05-20 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 3,051 | 17.99 | 54.9K | 133,307 | D | ↗ |
| 2025-05-14 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 34,000 | 15.94 | 542.0K | 3,238,199 | I | ↗ |
| 2025-04-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 237 | 10.94 | 2.6K | 90,689 | D | ↗ |
| 2025-04-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 237 | 10.94 | 2.6K | 136,358 | D | ↗ |
| 2025-03-24 | Morrell Martha | Officer | A-Award | A | Stock Option (Right to Buy) | 19,850 | 12.30 | 244.2K | 19,850 | D | ↗ |
| 2025-03-21 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 935 | 12.02 | 11.2K | 11,000 | D | ↗ |
| 2025-03-21 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,247 | 12.02 | 15.0K | 14,154 | D | ↗ |
| 2025-03-21 | Geiger Uri | Director | A-Award | A | Common Stock | 987 | 12.02 | 11.9K | 10,896 | D | ↗ |
| 2025-03-21 | Fischer Frank M | Director | A-Award | A | Common Stock | 1,975 | 12.02 | 23.7K | 587,250 | D | ↗ |
| 2025-03-10 | Kuhn Rebecca | Officer | A-Award | A | Common Stock | 11,700 | 0.00 | — | 136,595 | D | ↗ |
| 2025-03-10 | Becker Joel | Director / Officer | A-Award | A | Stock Option (Rt to Buy) | 99,200 | 10.04 | 996.0K | 99,200 | D | ↗ |
| 2025-03-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,337 | 11.81 | 15.8K | 79,226 | D | ↗ |
| 2025-03-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,337 | 11.81 | 15.8K | 124,895 | D | ↗ |
| 2025-02-27 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,430 | 12.56 | 18.0K | 80,563 | D | ↗ |
| 2025-02-27 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,430 | 12.56 | 18.0K | 126,232 | D | ↗ |
| 2025-02-27 | Becker Joel | Director / Officer | F-InKind | D | Common Stock | 4,506 | 12.56 | 56.6K | 47,964 | D | ↗ |
| 2025-02-21 | Morrell Martha | Officer | S-Sale | D | Common Stock | 78,334 | 13.72 | 1.07M | 81,993 | D | ↗ |
| 2025-02-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,405 | 14.23 | 48.5K | 43,670 | D | ↗ |
| 2025-02-20 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 3,405 | 14.23 | 48.5K | 127,662 | D | ↗ |
| 2025-02-20 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 5,270,845 | 9.40 | 49.55M | 0 | D | ↗ |
| 2025-01-30 | Morrell Martha | Officer | S-Sale | D | Common Stock | 200 | 15.00 | 3.0K | 86,762 | D | ↗ |
| 2025-01-29 | Morrell Martha | Officer | S-Sale | D | Common Stock | 100 | 15.00 | 1.5K | 86,962 | D | ↗ |
| 2025-01-24 | Morrell Martha | Officer | S-Sale | D | Common Stock | 3,200 | 15.01 | 48.0K | 87,062 | D | ↗ |
| 2025-01-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 265 | 14.04 | 3.7K | 47,075 | D | ↗ |
| 2025-01-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 265 | 14.04 | 3.7K | 118,129 | D | ↗ |
| 2025-01-06 | Huennekens R Scott | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-21 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 975 | 11.53 | 11.2K | 10,065 | D | ↗ |
| 2024-12-21 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,300 | 11.53 | 15.0K | 12,907 | D | ↗ |
| 2024-12-21 | Geiger Uri | Director | A-Award | A | Common Stock | 1,029 | 11.53 | 11.9K | 9,909 | D | ↗ |
| 2024-12-21 | Fischer Frank M | Director | A-Award | A | Common Stock | 2,059 | 11.53 | 23.7K | 585,275 | D | ↗ |
| 2024-12-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,413 | 11.93 | 16.9K | 47,340 | D | ↗ |
| 2024-12-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,334 | 11.93 | 15.9K | 118,394 | D | ↗ |
| 2024-11-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,045 | 9.19 | 28.0K | 48,753 | D | ↗ |
| 2024-11-20 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 3,045 | 9.19 | 28.0K | 119,728 | D | ↗ |
| 2024-10-25 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 223,991 | 5.45 | 1.22M | 5,270,845 | D | ↗ |
| 2024-10-23 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 147 | 6.02 | 884.94 | 5,494,836 | D | ↗ |
| 2024-10-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 237 | 6.00 | 1.4K | 51,798 | D | ↗ |
| 2024-10-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 237 | 6.00 | 1.4K | 122,773 | D | ↗ |
| 2024-10-22 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,082 | 6.09 | 24.9K | 5,494,983 | D | ↗ |
| 2024-10-21 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 3,720 | 6.10 | 22.7K | 5,499,065 | D | ↗ |
| 2024-10-18 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,878 | 6.29 | 30.7K | 5,502,785 | D | ↗ |
| 2024-10-17 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 3,294 | 6.28 | 20.7K | 5,507,663 | D | ↗ |
| 2024-10-16 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 6,900 | 6.57 | 45.3K | 5,510,957 | D | ↗ |
| 2024-10-15 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,017 | 6.50 | 26.1K | 5,517,857 | D | ↗ |
| 2024-10-14 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,031 | 6.54 | 26.4K | 5,521,874 | D | ↗ |
| 2024-10-11 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 2,572 | 6.35 | 16.3K | 5,525,905 | D | ↗ |
| 2024-10-10 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 2,504 | 6.12 | 15.3K | 5,528,477 | D | ↗ |
| 2024-10-09 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 3,123 | 6.10 | 19.1K | 5,530,981 | D | ↗ |
| 2024-10-08 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 6,000 | 6.43 | 38.6K | 5,534,104 | D | ↗ |
| 2024-10-07 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,910 | 6.66 | 32.7K | 5,540,104 | D | ↗ |
| 2024-10-04 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 5,757 | 6.92 | 39.8K | 5,545,014 | D | ↗ |
| 2024-10-03 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 3,318 | 6.97 | 23.1K | 5,550,771 | D | ↗ |
| 2024-10-02 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 3,843 | 6.87 | 26.4K | 5,554,089 | D | ↗ |
| 2024-10-01 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,882 | 6.77 | 33.1K | 5,557,932 | D | ↗ |
| 2024-09-30 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 1,614 | 6.97 | 11.2K | 9,090 | D | ↗ |
| 2024-09-30 | Kumar Rakhi | Director | A-Award | A | Common Stock | 2,152 | 6.97 | 15.0K | 11,607 | D | ↗ |
| 2024-09-30 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,749 | 6.73 | 32.0K | 5,562,814 | D | ↗ |
| 2024-09-30 | Geiger Uri | Director | A-Award | A | Common Stock | 1,703 | 6.97 | 11.9K | 8,880 | D | ↗ |
| 2024-09-30 | Fischer Frank M | Director | A-Award | A | Common Stock | 3,407 | 6.97 | 23.7K | 583,216 | D | ↗ |
| 2024-09-27 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 5,059 | 6.63 | 33.5K | 5,567,563 | D | ↗ |
| 2024-09-26 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 5,821 | 6.62 | 38.5K | 5,572,622 | D | ↗ |
| 2024-09-25 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 5,858 | 6.60 | 38.7K | 5,578,443 | D | ↗ |
| 2024-09-23 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 282 | 7.54 | 2.1K | 5,584,301 | D | ↗ |
| 2024-09-20 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 765 | 7.50 | 5.7K | 5,584,583 | D | ↗ |
| 2024-09-13 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 1,993 | 7.59 | 15.1K | 5,585,348 | D | ↗ |
| 2024-09-06 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 11 | 7.50 | 82.50 | 5,587,341 | D | ↗ |
| 2024-09-04 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 14 | 7.50 | 105.00 | 5,587,352 | D | ↗ |
| 2024-09-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,334 | 7.39 | 9.9K | 52,035 | D | ↗ |
| 2024-09-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,334 | 7.39 | 9.9K | 123,010 | D | ↗ |
| 2024-09-03 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 2,093 | 7.60 | 15.9K | 5,587,366 | D | ↗ |
| 2024-08-30 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,314 | 7.76 | 33.5K | 5,589,459 | D | ↗ |
| 2024-08-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,045 | 7.24 | 22.0K | 53,369 | D | ↗ |
| 2024-08-20 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 3,045 | 7.24 | 22.0K | 124,344 | D | ↗ |
| 2024-07-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 237 | 7.65 | 1.8K | 56,414 | D | ↗ |
| 2024-07-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 237 | 7.65 | 1.8K | 127,389 | D | ↗ |
| 2024-06-28 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 1,488 | 7.56 | 11.2K | 7,476 | D | ↗ |
| 2024-06-28 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,984 | 7.56 | 15.0K | 9,455 | D | ↗ |
| 2024-06-28 | Geiger Uri | Director | A-Award | A | Common Stock | 1,570 | 7.56 | 11.9K | 7,177 | D | ↗ |
| 2024-06-28 | Fischer Frank M | Director | A-Award | A | Common Stock | 3,141 | 7.56 | 23.7K | 579,809 | D | ↗ |
| 2024-06-07 | Ryan Renee | Director | A-Award | A | Stock Option (Rt to Buy) | 17,774 | 6.47 | 115.0K | 17,774 | — | ↗ |
| 2024-06-07 | LACOB JOSEPH | Director | A-Award | A | Stock Option (Rt to Buy) | 17,774 | 6.47 | 115.0K | 17,774 | — | ↗ |
| 2024-06-07 | Kumar Rakhi | Director | A-Award | A | Stock Option (Rt to Buy) | 17,774 | 6.47 | 115.0K | 17,774 | — | ↗ |
| 2024-06-07 | Geiger Uri | Director | A-Award | A | Stock Option (Rt to Buy) | 17,774 | 6.47 | 115.0K | 17,774 | — | ↗ |
| 2024-06-07 | Fischer Frank M | Director | A-Award | A | Stock Option (Rt to Buy) | 17,774 | 6.47 | 115.0K | 17,774 | — | ↗ |
| 2024-06-07 | Andrade Lisa | Director | A-Award | A | Stock Option (Rt to Buy) | 17,774 | 6.47 | 115.0K | 17,774 | — | ↗ |
| 2024-06-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,335 | 6.46 | 8.6K | 56,511 | D | ↗ |
| 2024-06-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,334 | 6.46 | 8.6K | 127,626 | D | ↗ |
| 2024-05-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 3,045 | 7.98 | 24.3K | 57,986 | D | ↗ |
| 2024-05-20 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 3,045 | 7.98 | 24.3K | 128,960 | D | ↗ |
| 2024-05-03 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 4,674 | 14.03 | 65.6K | 3,406,335 | — | ↗ |
| 2024-05-02 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 8,842 | 14.01 | 123.9K | 3,411,009 | — | ↗ |
| 2024-05-01 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 15,690 | 14.02 | 220.0K | 3,419,851 | — | ↗ |
| 2024-04-24 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 1,781 | 14.06 | 25.0K | 3,435,541 | — | ↗ |
| 2024-04-23 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 21,791 | 14.29 | 311.4K | 3,437,322 | — | ↗ |
| 2024-04-22 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 24,609 | 14.05 | 345.8K | 3,459,113 | — | ↗ |
| 2024-04-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 237 | 14.00 | 3.3K | 61,268 | D | ↗ |
| 2024-04-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 237 | 14.00 | 3.3K | 132,005 | D | ↗ |
| 2024-04-19 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 18,253 | 14.02 | 255.9K | 3,483,722 | — | ↗ |
| 2024-04-18 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 2,623 | 14.06 | 36.9K | 3,501,975 | — | ↗ |
| 2024-04-17 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 300 | 14.15 | 4.2K | 3,504,598 | — | ↗ |
| 2024-04-16 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 14,069 | 14.01 | 197.1K | 3,504,898 | — | ↗ |
| 2024-04-12 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 23,101 | 14.42 | 333.1K | 3,518,967 | — | ↗ |
| 2024-04-11 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 461,899 | 14.49 | 6.69M | 3,542,068 | — | ↗ |
| 2024-03-29 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 852 | 13.20 | 11.2K | 5,988 | D | ↗ |
| 2024-03-29 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,136 | 13.20 | 15.0K | 7,471 | D | ↗ |
| 2024-03-29 | Geiger Uri | Director | A-Award | A | Common Stock | 899 | 13.20 | 11.9K | 5,607 | D | ↗ |
| 2024-03-29 | Fischer Frank M | Director | A-Award | A | Common Stock | 1,799 | 13.20 | 23.7K | 576,668 | D | ↗ |
| 2024-03-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,334 | 15.99 | 21.3K | 61,031 | D | ↗ |
| 2024-03-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,042 | 15.99 | 16.7K | 132,242 | D | ↗ |
| 2024-02-27 | Morrell Martha | Officer | A-Award | A | Stock Option (Right to Buy) | 24,950 | 17.11 | 426.9K | 24,950 | — | ↗ |
| 2024-02-27 | Kuhn Rebecca | Officer | A-Award | A | Stock Option (Right to Buy) | 24,950 | 17.11 | 426.9K | 24,950 | — | ↗ |
| 2024-02-27 | Becker Joel | Director / Officer | A-Award | A | Common Stock | 52,470 | 0.00 | — | 52,470 | — | ↗ |
| 2024-02-20 | Morrell Martha | Officer | F-InKind | D | Common Stock | 12,474 | 17.50 | 218.3K | 62,602 | D | ↗ |
| 2024-02-20 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 9,832 | 17.50 | 172.1K | 133,284 | D | ↗ |
| 2024-02-12 | Morrell Martha | Officer | M-Exempt | D | Stock Option (Rt to Buy) | 50,000 | 0.03 | 1.3K | 140,449 | D | ↗ |
| 2024-02-05 | Morrell Martha | Officer | S-Sale | D | Common Stock | 3,446 | 15.17 | 52.3K | 77,762 | — | ↗ |
| 2024-02-02 | Morrell Martha | Officer | S-Sale | D | Common Stock | 14,143 | 15.07 | 213.1K | 81,208 | — | ↗ |
| 2024-02-01 | Morrell Martha | Officer | S-Sale | D | Common Stock | 663 | 15.04 | 10.0K | 95,351 | — | ↗ |
| 2024-01-31 | Morrell Martha | Officer | M-Exempt | A | Common Stock | 192 | 0.03 | 4.99 | 44,054 | D | ↗ |
| 2024-01-30 | Morrell Martha | Officer | S-Sale | D | Common Stock | 11,262 | 15.10 | 170.0K | 97,937 | — | ↗ |
| 2024-01-25 | Morrell Martha | Officer | S-Sale | D | Common Stock | 1 | 15.00 | 15.00 | 109,199 | — | ↗ |
| 2024-01-24 | Morrell Martha | Officer | S-Sale | D | Common Stock | 827 | 15.03 | 12.4K | 109,200 | — | ↗ |
| 2024-01-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 264 | 14.84 | 3.9K | 75,076 | D | ↗ |
| 2024-01-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 212 | 14.84 | 3.1K | 143,116 | D | ↗ |
| 2023-12-29 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 1,091 | 10.31 | 11.2K | 5,136 | D | ↗ |
| 2023-12-29 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,454 | 10.31 | 15.0K | 6,335 | D | ↗ |
| 2023-12-29 | Geiger Uri | Director | A-Award | A | Common Stock | 1,151 | 10.31 | 11.9K | 4,708 | D | ↗ |
| 2023-12-29 | Fischer Frank M | Director | A-Award | A | Common Stock | 2,303 | 10.31 | 23.7K | 574,869 | D | ↗ |
| 2023-12-27 | Morrell Martha | Officer | S-Sale | D | Common Stock | 13,300 | 10.12 | 134.6K | 110,027 | — | ↗ |
| 2023-12-26 | Morrell Martha | Officer | S-Sale | D | Common Stock | 102 | 10.00 | 1.0K | 123,327 | — | ↗ |
| 2023-12-20 | Morrell Martha | Officer | S-Sale | D | Common Stock | 2,730 | 10.14 | 27.7K | 123,429 | — | ↗ |
| 2023-12-06 | Morrell Martha | Officer | S-Sale | D | Common Stock | 11,005 | 8.16 | 89.8K | 126,159 | — | ↗ |
| 2023-12-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,303 | 8.90 | 11.6K | 75,340 | D | ↗ |
| 2023-12-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,010 | 8.90 | 9.0K | 143,328 | D | ↗ |
| 2023-12-01 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 3,241 | 8.73 | 28.3K | 5,593,773 | — | ↗ |
| 2023-11-30 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 7,282 | 8.84 | 64.4K | 5,597,014 | — | ↗ |
| 2023-11-29 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 5,644 | 8.72 | 49.2K | 5,604,296 | — | ↗ |
| 2023-11-28 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 4,681 | 8.75 | 41.0K | 5,609,940 | — | ↗ |
| 2023-11-27 | KCK LTD. | 10% Owner | S-Sale | D | Common Stock | 6,490 | 8.96 | 58.2K | 5,614,621 | — | ↗ |
| 2023-10-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 231 | 6.88 | 1.6K | 76,643 | D | ↗ |
| 2023-10-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 179 | 6.88 | 1.2K | 144,338 | D | ↗ |
| 2023-10-03 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 700 | 9.02 | 6.3K | 4,003,967 | — | ↗ |
| 2023-10-02 | ORBIMED ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 7,614 | 9.08 | 69.1K | 4,004,667 | — | ↗ |
| 2023-09-29 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 1,156 | 9.73 | 11.2K | 4,045 | D | ↗ |
| 2023-09-29 | Kumar Rakhi | Director | A-Award | A | Common Stock | 1,541 | 9.73 | 15.0K | 4,881 | D | ↗ |
| 2023-09-29 | Geiger Uri | Director | A-Award | A | Common Stock | 1,220 | 9.73 | 11.9K | 3,557 | D | ↗ |
| 2023-09-29 | Fischer Frank M | Director | A-Award | A | Common Stock | 2,440 | 9.73 | 23.7K | 572,566 | D | ↗ |
| 2023-09-03 | Morrell Martha | Officer | F-InKind | D | Common Stock | 1,302 | 8.93 | 11.6K | 76,874 | D | ↗ |
| 2023-09-03 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 1,010 | 8.93 | 9.0K | 144,517 | D | ↗ |
| 2023-07-22 | Morrell Martha | Officer | F-InKind | D | Common Stock | 231 | 4.13 | 954.03 | 78,176 | D | ↗ |
| 2023-07-22 | Kuhn Rebecca | Officer | F-InKind | D | Common Stock | 179 | 4.13 | 739.27 | 145,527 | D | ↗ |
| 2023-07-18 | Becker Joel | Director / Officer | A-Award | A | Stock Option (Rt to Buy) | 380,424 | 4.39 | 1.67M | 380,424 | — | ↗ |
| 2023-07-10 | Becker Joel | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-30 | LACOB JOSEPH | Director | A-Award | A | Common Stock | 2,505 | 4.49 | 11.2K | 2,889 | D | ↗ |
| 2023-06-30 | Kumar Rakhi | Director | A-Award | A | Common Stock | 3,340 | 4.49 | 15.0K | 3,340 | D | ↗ |
Executive team
Top executives
EBIT / Employee
-80.5K
Shares Outstanding
33.95M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joel Becker President and Chief Executive Officer | 567.6K | — | 587.3K | 701.9K | 551.8K | — | 2.41M | 53.53% | ↗ |
| 2 | 2025 | Patrick Williams Chief Financial Officer | 263.5K | — | 539.8K | 650.5K | 192.3K | — | 1.65M | 72.31% | ↗ |
| 3 | 2025 | Martha Morrell, M.D. Chief Medical Officer | 489.8K | — | 140.6K | 168.2K | 235.5K | — | 1.03M | 29.86% | ↗ |
| 4 | 2025 | Rebecca Kuhn Former Chief Financial Officer, Vice President, Finance and Administration | 268.2K | — | 117.5K | 140.4K | — | 320.2K | 846.3K | 30.47% | ↗ |
| 5 | 2024 | Joel Becker President and Chief Executive Officer | 528.7K | — | 897.8K | 1.21M | 391.7K | — | 3.02M | 69.57% | ↗ |
| 6 | 2024 | Martha Morrell, M.D. Chief Medical Officer | 486.7K | — | 213.9K | 287.5K | 181.5K | — | 1.17M | 42.87% | ↗ |
| 7 | 2024 | Rebecca Kuhn Chief Financial Officer, Vice President, Finance and Administration | 416.2K | — | 213.9K | 287.5K | 175.7K | — | 1.09M | 45.86% | ↗ |
| 8 | 2024 | Rebecca Kuhn Former Chief Financial Officer, Vice President, Finance and Administration | 416.2K | — | 213.9K | 287.5K | 175.7K | — | 1.09M | 45.86% | ↗ |
| 9 | 2023 | Michael Favet Former President and Chief Executive Officer | 288.5K | — | 1.20M | — | — | 689.2K | 2.18M | 55.14% | ↗ |
| 10 | 2023 | Joel Becker President and Chief Executive Officer | 248.3K | — | — | 1.02M | 240.0K | — | 1.51M | 67.70% | ↗ |
| 11 | 2023 | Martha Morrell, M.D. Chief Medical Officer | 468.5K | — | 380.0K | — | 260.2K | — | 1.11M | 34.28% | ↗ |
| 12 | 2023 | Rebecca Kuhn Chief Financial Officer, Vice President, Finance and Administration, and Corporate Secretary | 403.5K | — | 380.0K | — | 211.4K | — | 994.9K | 38.19% | ↗ |
| 13 | 2023 | Rebecca Kuhn Chief Financial Officer, Vice President, Finance and Administration | 403.5K | — | 380.0K | — | 211.4K | — | 994.9K | 38.19% | ↗ |
| 14 | 2022 | Michael Favet, President and Chief Executive Officer | 538.7K | — | 1.26M | 1.25M | 161.5K | 504.00 | 3.21M | 78.15% | ↗ |
| 15 | 2022 | Michael Favet Former President and Chief Executive Officer | 538.7K | — | 1.26M | 1.25M | 161.5K | — | 3.21M | 78.16% | ↗ |
| 16 | 2022 | Martha Morrell, M.D., Chief Medical Officer | 453.0K | — | 381.1K | 378.8K | 102.5K | 328.00 | 1.32M | 57.75% | ↗ |
| 17 | 2022 | Martha Morrell, M.D. Chief Medical Officer | 453.0K | — | 381.1K | 378.8K | 102.5K | — | 1.32M | 57.77% | ↗ |
| 18 | 2022 | Irina Ridley, Chief Legal Officer and Corporate Secretary | 378.5K | — | 464.4K | 338.3K | 120.3K | 504.00 | 1.30M | 61.65% | ↗ |
| 19 | 2021 | Michael Favet, President and Chief Executive Officer | 505.8K | — | 611.8K | 629.1K | 329.6K | 504.00 | 2.08M | 59.75% | ↗ |
| 20 | 2021 | Irina Ridley, Chief Legal Officer and Corporate Secretary | 359.2K | — | 130.7K | 415.6K | 102.9K | 504.00 | 1.01M | 54.15% | ↗ |
| 21 | 2021 | Irina Ridley, General Counsel and Corporate Secretary | 359.2K | — | 130.7K | 415.6K | 102.9K | — | 1.01M | 54.18% | ↗ |
| 22 | 2021 | Martha Morrell, M.D., Chief Medical Officer | 435.7K | — | 188.3K | 193.1K | 147.8K | 401.00 | 965.3K | 39.51% | ↗ |
| 23 | 2020 | Michael Favet, President and Chief Executive Officer | 411.9K | 25.0K | — | 13.4K | 221.3K | — | 671.6K | 1.99% | ↗ |
| 24 | 2020 | Martha Morrell, M.D., Chief Medical Officer | 398.0K | — | — | 3.8K | 82.2K | — | 484.0K | 0.79% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joel D. Becker | Chief Executive Officer, President & Director | 1M | male |
| Martha J. Morrell | Chief Medical Officer | 725.3K | — |
| Patrick F. Williams | Chief Financial Officer | 689.4K | male |
| Rebecca L. Kuhn | Advisor | 588.4K | female |
| Leah Akin | General Counsel & Corporate Secretary | — | female |
| Amy Treadwell | Vice President of Human Resources | — | female |
| Scott R. Schaper | Head of Investor Relations | — | male |
| Chris Reese | Senior Vice President of Sales | — | male |
| Dylan John | Chief of Operations & Development | — | male |
| Katie Keller | Vice President of Marketing | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NPCE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
